Baby drug dosing study aims to prevent post-surgery breathing problems

This study will find the correct dose of sugammadex, a drug that reverses muscle relaxants, for infants under 2 years old. About 99 babies having non-emergency surgery will receive small, increasing doses until their muscle function returns. The goal is to ensure safe and complete reversal, reducing the risk of breathing difficulties after surgery.